Levites Y, Das P, Price RW, Rochette MJ, Kostura LA, McGowan EM, Murphy MP, Golde TE. Anti-Abeta42- and anti-Abeta40-specific mAbs attenuate amyloid deposition in an Alzheimer disease mouse model. J Clin Invest. 2006 Jan;116(1):193-201. PubMed.

Recommends

Please login to recommend the paper.

Comments

  1. These reports all seem very interesting and important provided that amyloid has a primary and not a secondary role in neurodegeneration or even the reverse, a protective role. If so, could that explain the negative effect of active and now also of passive immunisation as reported by the John Trojanowski group?
    Alzforum is a truly great asset!

    View all comments by Arne Brun

  2. This has helped me very much, because I have a report for school and you gave me a lot of information. Thanks!

    View all comments by Theodore Muench

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

News

  1. Passive Aggressive—Must Antibody Therapy Start Early to Be Effective?
  2. Short-term Aβ Suppression May Reap Long-term Benefits